Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
211
days
GPX3 suppresses lung adenocarcinoma progression through HSPB1 ubiquitination and Hippo pathway activation
Authors
Sixuan Wu; He Huang; Junfan Pan; Yaqin Zheng; Qihong Pan; Sihui Chen; Jing Zhang; Yuehua Li; Yiquan XuShow moreShow less
Affiliations
Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, China; Department of Oncology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang 421001, China; Endoscopy Center, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China; Interdisciplinary Institute of Medical Engineering of Fuzhou University, Fuzhou 350108, China; Department of Thoracic Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, China; NHC Key Laboratory of Cancer and Metabolism (Fujian Cancer Hospital), Fuzhou 350014, Fujian Province, ChinaShow moreShow less
119
days
A cross-species drug-discovery platform to accelerate the identification of lifespan-extending interventions
Authors
Kevin Perez; Lucas Schoenfeldt; Grace B. Phelps; Alberto Parras; Jonas Morin; Carla Pinto; Sebastien Guilmot; Tadeu Oliveira; Maria Silveira; Luca Dolfi; Alejandro OcampoShow moreShow less
Affiliations
EPITERNA, 1066 Épalinges, Switzerland; Institute of Oncology Research (IOR), 6500 Bellinzona, Switzerland; Università della Svizzera Italiana, 6900 Lugano, Switzerland; École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland; University of Lausanne, 1011 Lausanne, SwitzerlandShow moreShow less
174
days
An Epstein-Barr virus-encoded snoRNA directs 2′-O-methylation of human rRNAs to control translation and the viral lytic switch
Authors
Yarden Dan; Beáta E. Jády; Yudit Halperin; Yuval Nevo; Aliza Fedorenko; Anat Bashan; Maram Arafat; Pnina Glick; Ada Yonath; Tamás Kiss; Daphna NachmaniShow moreShow less
Affiliations
Department of Genetics, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 91904, Israel; Molecular, Cellular, and Developmental Biology Department (MCD) UMR 5077, Centre de Biologie Intégrative (CBI), University of Toulouse, Centre National de la Recherche Scientifique, 31062 Toulouse, France; Info-CORE, Bioinformatics Unit of the I-CORE at the Hebrew University of Jerusalem and Hadassah Medical Center, Jerusalem 91120, Israel; Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, IsraelShow moreShow less
186
days
Mesenchymal drift in ciliopathy iPSC-derived RPE reveals a convergent pathogenic cell state
Authors
Dominik Reichert; Sena Gul; Davide Ortolan; David McGaughey; Jair Montford; Jiwon Ryu; Alyssa S. Jeffrey; Colby F. Lewallen; Kati Veres; Rafael Villasmil; Noor D. White Carreiro; Stephen H. Tsang; Laryssa A. Huryn; Brian P. Brooks; Wadih Zein; Helen Louise May-Simera; Ruchi Sharma; Kapil BhartiShow moreShow less
Affiliations
Ocular and Stem Cell Translational Research Section, National Eye Institute, NIH, Bethesda, MD 20892, USA; Ciliary Cell Biology, Institute of Molecular Physiology, Faculty of Biology, Johannes Gutenberg-University, Mainz, Germany; Ophthalmic Genetics and Visual Function Branch, National Eye Institute, NIH, Bethesda, MD 20892, USA; Flow Cytometry Core, National Eye Institute, NIH, Bethesda, MD 20892, USA; Biological Imaging Core, National Eye Institute, NIH, Bethesda, MD 20892, USA; Departments of Ophthalmology, Pathology & Cell Biology, Columbia Stem Cell Initiative, New York, NY 10032, USAShow moreShow less
107
days
Prohibitin controls MRS2-Mediated mitochondrial Mg2+ uptake to Shape bioenergetics
Authors
Soumya Maity; Manigandan Venkatesan; Adhishree Chidambaram; Sukanthathulse Uthayabalan; Louis Tung Faat Lai; Nicholas D. Clark; Abhinaya Lakkureddi; Karthik Ramachandran; Kristen Bentz; Ravi Ramalingam; Sanjana Sen; Moeez Akram; Susan T. Weintraub; Brij B. Singh; David Gius; Joseph A. Baur; Arianne L. Theiss; Jeffrey Caplan; Doreen Matthies; Peter B. Stathopulos; Muniswamy MadeshShow moreShow less
Affiliations
Center for Mitochondrial Medicine, Department of Medicine, University of Texas Health San Antonio, San Antonio, TX 78229, USA; Department of Physiology and Pharmacology, Western University, London, ON N6A 5C1, Canada; Unit on Structural Biology, Division of Basic and Translational Biophysics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA; Department of Periodontics, University of Texas Health San Antonio, San Antonio, TX 78229, USA; Department of Radiation Oncology, Mays Cancer Center MD Anderson, and the Joe R. and Teresa Lozano Long School of Medicine, University of Texas San Antonio Health Science Center, San Antonio, TX, USA; Department of Physiology and Institute for Diabetes, Obesity, and Metabolism, University of Pennsylvania, Philadelphia, PA 19103, USA; Division of Gastroenterology and Hepatology, Department of Medicine, University of Colorado School of Medicine and Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, CO 80045, USA; Department of Biological Sciences, Delaware Biotechnology Institute, University of Delaware, Newark, DE 19711, USAShow moreShow less
138
days
Loss of laminin-γ1 in pericytes impairs microvascular function and cognition
Authors
Jingsong Ruan; Ava Nasrollahi; Cecilia Martin; Meisam Asgari; Andy Y. Shih; Yao YaoShow moreShow less
Affiliations
Department of Molecular Pharmacology and Physiology, Morsani College of Medicine, University of South Florida, Tampa, FL, USA; Center for Developmental Biology and Regenerative Medicine, Seattle Children’s Research Institute, Seattle, WA, USA; Department of Medical Engineering, University of South Florida, Tampa, FL, USA; Department of Pediatrics, University of Washington, Seattle, WA, USA; Department of Bioengineering, University of Washington, Seattle, WA, USAShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days